Runben Biotechnology Co., Ltd. engages in the research, production, and sale of mosquito repellent products, infant care products, and essential oil products. T...
Runben Biotechnology released its performance for the first three quarters, with a net profit attributable to the parent company of 266 million yuan, a year-on-year increase of 1.98%
Runben Biotechnology 2025 Half-Year Equity Distribution: Cash Dividend of 0.2 Yuan per Share
Runben Biotechnology released its performance for the first half of the year, with a net profit attributable to the parent company of 188 million yuan, an increase of 4.16%
This week's largest increase in margin financing balance: Runben Biotechnology margin financing balance: 326 million yuan, balance increase: 147.62%; SOKAN margin financing balance: 125 million yuan, balance increase: 103.81%
Global Growth Companies With High Insider Ownership To Watch
The beauty and personal care sector rises, Runben Biotechnology hits the limit up